Finance

Lists
EWL:ETR
Edwards Lifesciences Corp
76,64 €
-0,05%
(-0,040) 1D
13 հոկ, 17:35:45 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EWL...
Open
77,52 €
High
77,58 €
Low
76,62 €
Mkt. cap
49,47 մլրդ
Avg. vol.
54,00
Volume
90,00
52-wk high
84,00 €
52-wk low
62,00 €
No. of employees
16 հզր
Open
77,52 €
High
77,58 €
Low
76,62 €
Mkt. cap
49,47 մլրդ
Avg. vol.
54,00
Volume
90,00
52-wk high
84,00 €
52-wk low
62,00 €
No. of employees
16 հզր
News stories
From web sources and news partners
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 հզր
Founded1958
HeadquartersԻրվայն, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,55 մլրդ
1,57 մլրդ
1,65 մլրդ
1,74 մլրդ
Cost of goods sold
345,20 մլն
343,00 մլն
362,60 մլն
392,40 մլն
Cost of revenue
345,20 մլն
343,00 մլն
362,60 մլն
392,40 մլն
Research and development expenses
280,70 մլն
267,70 մլն
263,30 մլն
278,90 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
514,60 մլն
601,20 մլն
522,20 մլն
561,20 մլն
Operating expense
782,80 մլն
854,60 մլն
771,30 մլն
829,10 մլն
Total operating expenses
1,13 մլրդ
1,20 մլրդ
1,13 մլրդ
1,22 մլրդ
Operating income
425,10 մլն
372,00 մլն
514,70 մլն
519,50 մլն
Other non operating income
1,10 մլն
2,30 մլն
69,90 մլն
-25,00 մլն
EBT including unusual items
348,40 մլն
90,40 մլն
459,00 մլն
519,80 մլն
EBT excluding unusual items
444,50 մլն
464,00 մլն
603,60 մլն
511,10 մլն
Income tax expense
56,10 մլն
26,20 մլն
78,30 մլն
278,40 մլն
Effective tax rate
16,10%
28,98%
17,06%
53,56%
Other operating expenses
-12,50 մլն
-14,30 մլն
-14,20 մլն
-11,00 մլն
Net income
291,10 մլն
91,20 մլն
380,70 մլն
241,90 մլն
Net profit margin
18,74%
5,81%
23,09%
13,89%
Earnings per share
0,67
0,58
0,78
0,78
Interest and investment income
16,70 մլն
114,20 մլն
17,40 մլն
15,00 մլն
Interest expense
-
-20,40 մլն
-
-
Net interest expenses
16,70 մլն
93,80 մլն
17,40 մլն
15,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
464,30 մլն
414,70 մլն
555,60 մլն
562,20 մլն
Gain or loss from assets sale
-
-33,90 մլն
-
-
AI content may include mistakes. Learn more
Google Apps